XOMA CORP.PRF.SH.SER.A 25

Research XOMA CORP.PRF.SH.SER.A 25 (X0M) on Bullrun: P/E 22.5, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerX0M
• ExchangeF
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• P/E22.5
• Dividend yield0.1%
• Financial periodQ4 2025
• RevenueEUR 1.43M
• Net incomeEUR 6.10M
• Free cash flow-EUR 5.50M

Valuation Snapshot

P/E is 22.5; dividend yield is 0.1%.

About XOMA CORP.PRF.SH.SER.A 25

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers;

Frequently asked questions

What is XOMA CORP.PRF.SH.SER.A 25's P/E ratio?

XOMA CORP.PRF.SH.SER.A 25's price-to-earnings (P/E) ratio is 22.5.

Does XOMA CORP.PRF.SH.SER.A 25 pay a dividend?

XOMA CORP.PRF.SH.SER.A 25 has a dividend yield of 0.1%.

What does XOMA CORP.PRF.SH.SER.A 25 do?

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates.